VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 365 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,380,000 | -23.4% | 68,500 | 0.0% | 0.36% | -8.4% |
| Q1 2016 | $1,802,000 | -47.5% | 68,500 | +103.0% | 0.39% | -22.1% |
| Q4 2015 | $3,431,000 | +22.1% | 33,750 | +114.3% | 0.50% | +40.2% |
| Q3 2015 | $2,809,000 | -72.4% | 15,750 | -65.6% | 0.36% | -64.0% |
| Q2 2015 | $10,163,000 | +11.8% | 45,750 | 0.0% | 1.00% | +5.2% |
| Q1 2015 | $9,087,000 | -35.6% | 45,750 | -53.6% | 0.95% | -60.6% |
| Q4 2014 | $14,103,000 | +9.1% | 98,550 | 0.0% | 2.40% | +50.5% |
| Q3 2014 | $12,930,000 | – | 98,550 | – | 1.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |